SEC Closes Investigation of Insys Therapeutics Without Enforcement Action

December 05, 2018

On October 4, 2018, the SEC closed its investigation of Cravath client Insys Therapeutics without any enforcement action against the company. The investigation related to Insys’ financial restatement and disclosures, sales and marketing practices and compliance program.

The Cravath team was led by partner David M. Stuart and included associates Kate M. FitzGerald and Janice T. P. Martindale.

Related Practices & Industries

People

Photo
Name: Janice T. P. Martindale
Title: Corporate
Title: Of Counsel
Email: jmartindale@cravath.com
Phone: +1-212-474-1616
vCard: Download vCard

Photo
Name: David M. Stuart
Title: Litigation
Title: Retired Partner
Email: dstuart@cravath.com
Phone: +1-212-474-1519
vCard: Download vCard

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

SEC Closes Investigation of Insys Therapeutics Without Enforcement Action

Education

Admitted In

Education

Cravath Bicentennial